You are here:

Takeda UK Ltd

Name SMC ID No Status Sub. Type
 
alogliptin (Vipidia) 937/14 Not Recommended Full submission
alogliptin (Vipidia) 937/14 Restricted Resubmission
alogliptin plus metformin (Vipdomet) 998/14 Restricted Abbreviated Submission
azilsartan medoxomil (Edarbi) 803/12 Not Recommended Non submission
brentuximab vedotin (Adcetris) 845/12 Not Recommended Non submission
brentuximab vedotin (Adcetris) 845/12 Restricted Full submission
Candesartan cilexetil (Amias®) 161/05 Accepted Full submission
ferumoxytol (Rienso) 833/13 Marketing Authorisation Withdrawn Full submission
mifamurtide (Mepact) 621/10 Not Recommended Full submission
mifamurtide (Mepact) 621/10 Accepted Resubmission
Pioglitazone (Actos®) 115/04 Restricted Resubmission
Pioglitazone (Actos®) 115/04 Not Recommended Full submission
pioglitazone 15mg, 30mg and 45mg tablets (Actos) 399/07 Accepted Full submission
pioglitazone 15mg, 30mg and 45mg tablets (Actos® triple therapy) 354/07 Restricted Full submission
Pioglitazone 15mg/metformin 850mg hydrochloride (Competact) 252/06 Restricted Abbreviated Submission
vedolizumab (Entyvio) 1045/15 Accepted Full submission
vedolizumab (Entyvio) 1064/15 Restricted Full submission

Back